Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
J Cardiovasc Comput Tomogr. 2019 Sep-Oct;13(5):288-296. doi: 10.1016/j.jcct.2019.03.006. Epub 2019 Mar 29.
Perivascular adipose tissue (PVAT) surrounding the human coronary arteries, secretes a wide range of adipocytokines affecting the biology of the adjacent vascular wall in a paracrine way. However, we have recently found that PVAT also behaves as a sensor of signals coming from the vascular wall, to which it reacts by changing its morphology and secretory profile. Indeed, vascular inflammation, a key feature of vascular disease pathogenesis, leads to the release of inflammatory signals that disseminate into local fat, inducing local lipolysis and inhibiting adipogenesis. This ability of PVAT to sense inflammatory signals from the vascular wall, can be used as a "thermometer" of the vascular wall, allowing for non-invasive detection of coronary inflammation. Vascular inflammation induces a shift of PVAT's composition from lipid to aqueous phase, resulting into increased computed tomography (CT) attenuation around the inflamed artery, forming a gradient with increasing attenuation closer to the inflamed coronary artery wall. These spatial changes in PVAT's attenuation are easily detected around culprit lesions during acute coronary syndromes. A new biomarker designed to captured these spatial changes in PVAT's attenuation around the human coronary arteries, the Fat Attenuation Index (FAI), has additional predictive value in stable patients for cardiac mortality and non-fatal heart attacks, above the prediction provided by the current state of the art that includes risk factors, calcium score and presence of high risk plaque features. The use of perivascular FAI in clinical practice may change the way we interpret cardiovascular CT angiography, as it is applicable to any coronary CT angiogram, and it offers dynamic information about the inflammatory burden of the coronary arteries, providing potential guidance for preventive measures and invasive treatments.
人冠状动脉周围的血管周脂肪组织 (PVAT) 分泌广泛的脂肪细胞因子,以旁分泌的方式影响邻近血管壁的生物学特性。然而,我们最近发现,PVAT 还可以作为血管壁信号的传感器,通过改变其形态和分泌谱来对来自血管壁的信号做出反应。事实上,血管炎症是血管疾病发病机制的一个关键特征,它会导致炎症信号的释放,这些信号会扩散到局部脂肪中,引起局部脂肪分解并抑制脂肪生成。PVAT 感知血管壁炎症信号的这种能力,可以作为血管壁的“温度计”,允许对冠状动脉炎症进行非侵入性检测。血管炎症会导致 PVAT 的组成从脂质相转变为水相,导致受炎症影响的动脉周围 CT 衰减增加,与受炎症影响的冠状动脉壁的距离越近,衰减梯度越大。在急性冠状动脉综合征期间,这些 PVAT 衰减的空间变化很容易在罪犯病变周围检测到。一种旨在捕捉人冠状动脉周围 PVAT 衰减空间变化的新型生物标志物,即脂肪衰减指数 (FAI),在稳定型患者中对心脏死亡率和非致死性心脏病发作的预测价值高于目前包括风险因素、钙评分和存在高危斑块特征的最新技术水平提供的预测。在临床实践中使用血管周 FAI 可能会改变我们对心血管 CT 血管造影的解释方式,因为它适用于任何冠状动脉 CT 血管造影,并且它提供了关于冠状动脉炎症负担的动态信息,为预防措施和有创治疗提供了潜在的指导。